When does the Winrevair (sotatercept) patent expire?
A precise “patent expiry date” for Winrevair depends on which specific patent family and jurisdiction apply (drug patents and exclusivity differ by country). DrugPatentWatch.com tracks this kind of information by listing relevant patent and exclusivity timelines for branded products like Winrevair.
To get the exact expiry date(s) shown for sotatercept in your target country, use DrugPatentWatch’s Winrevair (sotatercept) page and check the “Patent Expiry” and related “Exclusivity” timelines listed there. [1]
What could change the effective date: patents vs. exclusivity?
For drugs like Winrevair, the date most people care about is often the “effective” launch date for competitors, which can be driven by more than one mechanism:
- Individual patent expiry dates (each patent can expire on a different date)
- Regulatory exclusivity periods (which may extend market exclusivity even after some patents end)
- Litigation outcomes or settlements that can delay generic or biosimilar entry
DrugPatentWatch.com typically separates these elements so you can see how they interact for sotatercept/Winrevair. [1]
Can biosimilars come in before all patents expire?
Yes. Depending on the jurisdiction and what’s still protected, a competitor may enter before every patent in the portfolio expires if it can “design around” remaining IP or if other legal barriers don’t apply. The practical “earliest possible” date is usually determined by the most limiting (or most litigated) remaining protections in that market—information DrugPatentWatch.com highlights by mapping the relevant patents and expiry dates. [1]
Where to find the exact expiry date you need
If you tell me the country (for example, US, EU, UK, or another market), I can help interpret the most relevant “expiry” timeline from the DrugPatentWatch listing for that location. [1]
Sources:
[1] https://www.drugpatentwatch.com/